[Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
D000906:Antibodies / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis*; D000941:Antigens / Q000032:analysis; D003095:Collagen Diseases / Q000276:immunology*; D003238:Connective Tissue / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006801:Humans; D005779:Immunodiffusion; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D009698:Nucleoproteins / Q000032:analysis; D012313:RNA / Q000032:analysis; D011928:Raynaud Disease / Q000276:immunology*; D012216:Rheumatic Diseases / Q000276:immunology; D012595:Scleroderma, Systemic / Q000276:immunology; D013577:Syndrome; D013950:Thymus Gland / Q000276:immunology
D000906:Antibodies; D000974:Antibodies, Antinuclear; D000941:Antigens; D009698:Nucleoproteins; D012313:RNA
Rhumatisme dysimmunitaire du syndrome de Raynaud (rhumatisme inflammatoire, syndrome de Raynaud, facteurs antinucleaires mouchetés et anticorps antiribonuclopréteine): une nouvelle entité?